Literature DB >> 30818998

Altered morpho-functional features of bones in autoimmune disease-prone BXSB/MpJ- Yaa mice.

Takashi Namba1, Osamu Ichii1, Teppei Nakamura1,2, Md Abdul Masum1, Yuki Otani1, Saori Otsuka-Kanazawa1, Yaser Hosny Ali Elewa1,3, Yasuhiro Kon1.   

Abstract

IMPACT STATEMENT: Bone disease, such as osteoporosis and rheumatoid arthritis, increases because of the progression of an aging society. Autoimmune disease are important and predisposing factors for the pathogenesis of the bone disease; however, the pathological mechanism is unclear. We have demonstrated that systemic autoimmune disease in BXSB/MpJ- Yaa is closely associated with the morpho-functional abnormalities of bones including bone marrow and has complicated pathology. The abnormalities are characterized by altered regulations of serum calcium, anemia tendency, and hematopoiesis with increased WBCs and decreased PLs, short length and low mass of long bones, imbalance in the populations of osteoclasts and osteoblasts, and increased expression of candidate genes for causing and/or exacerbating their phenotypes. Therefore, BXSB/MpJ- Yaa serves as a model to elucidate bone phenotypes in systemic autoimmune disease that would be affected by the factors in the bone as well as the other immune and/or mineral metabolism organs both in human and experimental medicine.

Entities:  

Keywords:  Autoimmune disease; BXSB/MpJ-Yaa; bone; calcium; hematology; histopathology

Mesh:

Year:  2019        PMID: 30818998      PMCID: PMC6488867          DOI: 10.1177/1535370219832810

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  49 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 2.  Genetic regulation of osteoclast development and function.

Authors:  Steven L Teitelbaum; F Patrick Ross
Journal:  Nat Rev Genet       Date:  2003-08       Impact factor: 53.242

3.  Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment.

Authors:  Rowena McBeath; Dana M Pirone; Celeste M Nelson; Kiran Bhadriraju; Christopher S Chen
Journal:  Dev Cell       Date:  2004-04       Impact factor: 12.270

4.  Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register.

Authors:  G Haugeberg; T Uhlig; J A Falch; J I Halse; T K Kvien
Journal:  Arthritis Rheum       Date:  2000-03

5.  Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoA.

Authors:  S K Prakash; R Paylor; S Jenna; N Lamarche-Vane; D L Armstrong; B Xu; M A Mancini; H Y Zoghbi
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

Review 6.  Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models.

Authors:  Yoichiro Iwakura
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

7.  Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.

Authors:  Manali S Bendre; Donna C Montague; Terry Peery; Nisreen S Akel; Dana Gaddy; Larry J Suva
Journal:  Bone       Date:  2003-07       Impact factor: 4.398

8.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

Review 9.  Evolving concepts of rheumatoid arthritis.

Authors:  Gary S Firestein
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

10.  Intracellular membrane trafficking pathways in bone-resorbing osteoclasts revealed by cloning and subcellular localization studies of small GTP-binding rab proteins.

Authors:  Haibo Zhao; Otto Ettala; H Kalervo Väänänen
Journal:  Biochem Biophys Res Commun       Date:  2002-05-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.